Uncategorized
IRIS Registry a great way to simplify practice post-Affordable Care Act, speaker says
NEW ORLEANS – The American Academy of Ophthalmology’s Intelligent Research in Sight Registry is a useful tool for managing the difficulty cornea and external disease practices may face in the wake of the Affordable Care Act, according to a speaker here. “Simplify where possible,” David B. Glasser, MD, said here at Cornea Subspecialty Day preceding the American Academy of Ophthalmology meeting. “The academy’s IRIS [Intelligent Research in Sight] Registry is a great way to do that if you’ve got a long-term health record.”